biodesix.com
Independent Directory - Important Information
This llms.txt file was publicly accessible and retrieved from biodesix.com. LLMS Central does not claim ownership of this content and hosts it for informational purposes only to help AI systems discover and respect website policies.
This listing is not an endorsement by biodesix.com and they have not sponsored this page. We are an independent directory service with no affiliation to the listed domain.
Copyright & Terms: Users should respect the original terms of service of biodesix.com. If you believe there is a copyright or terms of service violation, please contact us at support@llmscentral.com for prompt removal. Domain owners can also claim their listing.
Current llms.txt Content
# Biodesix > Biodesix (NASDAQ: BDSX) is a diagnostic solutions company specializing in lung disease, developing blood-based molecular tests and providing biopharmaceutical research services. The company is headquartered in Louisville, Colorado, with a second laboratory in De Soto, Kansas; both facilities are CLIA-certified and CAP-accredited. Biodesix was founded in 2006 and is led by Chief Executive Officer Scott Hutton. ## Diagnostic tests for healthcare providers - [Tests overview](https://www.biodesix.com/tests): Portfolio of Biodesix blood-based diagnostic tests for lung disease. - [IQLung test suite](https://www.biodesix.com/tests/iqlung): Blood-based tests for non-small cell lung cancer (NSCLC) treatment guidance â includes VeriStrat (host immune classifier), GeneStrat ddPCR (EGFR, ALK, KRAS, BRAF mutation detection), and GeneStrat NGS (52-gene panel). - [Nodify Lung test suite](https://www.biodesix.com/tests/nodify-lung): Blood-based tests for lung nodule risk assessment â includes Nodify CDT (seven-autoantibody panel) and Nodify XL2 (proteomic test). ## Patient resources - [Lung cancer patient resources](https://www.biodesix.com/patient/lung-cancer): Information for patients with non-small cell lung cancer about Biodesix's IQLung tests for treatment decisions. - [Lung nodule patient resources](https://www.biodesix.com/patient/lung-nodule): Information for patients with a newly identified lung nodule about Biodesix's Nodify Lung tests for risk assessment. ## Reimbursement and financial information - [Reimbursement](https://www.biodesix.com/resources/reimbursement): Insurance coverage, billing, and reimbursement guidance for Biodesix tests. ## Company - [About Biodesix](https://www.biodesix.com/company): Company overview, mission and vision, leadership philosophy, manufacturing, and research. - [Leadership](https://www.biodesix.com/company/leadership): Executive team and board of directors. - [Laboratory certifications](https://www.biodesix.com/company/labs-certifications): CLIA, CAP, ISO, and state clinical laboratory licenses held by the Colorado and Kansas labs. - [Community and philanthropy](https://www.biodesix.com/community-and-philanthropy): Biodesix's community engagement and philanthropic initiatives. - [Contact](https://www.biodesix.com/contact): Phone (1-866-432-5930), corporate headquarters and lab addresses, and contact form. ## Biopharmaceutical services - [Biopharma services](https://www.biodesix.com/services/biopharma-services): Biopharmaceutical research services including assay development, clinical sample testing, and regulatory support. - [Development services overview](https://www.biodesix.com/services/development-services-overview): Custom diagnostic assay development and validation. - [Life sciences services](https://www.biodesix.com/services/life-sciences): Life sciences research collaboration services. - [ESR1](https://www.biodesix.com/services/esr1): ESR1 mutation testing service. - [OncomineDx Express](https://www.biodesix.com/services/oncominedxexpress): OncomineDx Express targeted oncology NGS service. ## News and publications - [Newsroom](https://www.biodesix.com/newsroom): Biodesix news, announcements, and media hub. - [Press releases](https://www.biodesix.com/newsroom/press-releases): Official press releases. - [In the news](https://www.biodesix.com/newsroom/in-the-news): Media coverage of Biodesix. - [Presentations and events](https://www.biodesix.com/newsroom/presentations-events): Scientific presentations and conference appearances. - [Engagements and conferences](https://www.biodesix.com/newsroom/engagements-conferences): Upcoming and recent conference engagements. - [Media kit](https://www.biodesix.com/newsroom/media-kit): Logos, fact sheets, and press resources. - [Publications](https://www.biodesix.com/resources/publications): Peer-reviewed publications featuring Biodesix tests and research. ## Careers - [Working at Biodesix](https://www.biodesix.com/careers/working-at-biodesix): Company culture, values, and benefits. - [Current openings](https://www.biodesix.com/careers/current-openings): Open positions at Biodesix. ## Optional - [Privacy policy (HIPAA)](https://www.biodesix.com/privacy-policy-hipaa): Patient privacy policy and HIPAA Notice of Privacy Practices. - [GDPR notice](https://www.biodesix.com/gdpr): GDPR compliance and EU data protection notice. - [Terms and conditions](https://www.biodesix.com/terms-conditions): Website terms of use.
Version History
Categories
Visit Website
Explore the original website and see their AI training policy in action.
Visit biodesix.comContent Types
No content types identified
Recent Access
No recent access
